Conclusion
This case highlights the importance of closely monitoring medication induced hematologic side effects. Phenazopyridine is not a benign medication when used for prolonged periods of time and can induce hemolysis. Physicians and care providers must remain mindful of using phenazopyridine for symptomatic HC related dysuria.
Disclosures of funding : None